JMML
Showing 1 - 25 of 32
Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)
Not yet recruiting
- Leukemia, Juvenile Myelomonocytic
- +4 more
- Trametinib
- +3 more
- (no location specified)
May 4, 2023
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,
Completed
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +5 more
-
New York, New YorkColumbia University Medical Center
Aug 4, 2021
JMML Trial in Tianjin (Azacitidine and homoharringtonine)
Recruiting
- JMML
- Azacitidine and homoharringtonine
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Aug 6, 2020
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)
Terminated
- Leukemia, Myeloid, Chronic
- +8 more
- Stem Cell Transplant
- +5 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 31, 2020
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,
Completed
- Leukemia, Acute Lymphocytic (ALL)
- +7 more
- CliniMACS
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 3, 2020
MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)
Recruiting
- MDS/MPN
- Azacitidine (AZA) with Ruxolitinib
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), MDS (MDS) Trial in Worldwide (Treosulfan)
Completed
- Acute Lymphoblastic Leukaemias (ALL)
- +3 more
-
Vienna, Austria
- +23 more
Apr 30, 2020
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)
Recruiting
- Primary Myelofibrosis
- +9 more
- Observational
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Miltenyi CliniMACS Prodigy ® system
- (no location specified)
Mar 23, 2023
Advanced Translational Research on Childhood Leukemia
Recruiting
- Childhood Leukemia
- RNA-seq
- +2 more
-
Hong Kong, Hksar, ChinaHong Kong Children Hospital
Jul 26, 2021
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Juvenile Trial in Worldwide (Azacitidine)
Completed
- Myelodysplastic Syndrome
- Leukemia, Myelomonocytic, Juvenile
-
Vienna, Austria
- +38 more
Jul 9, 2019
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Juvenile Myelomonocytic Leukemia Trial in Worldwide (procedure, drug, other)
Completed
- Juvenile Myelomonocytic Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Birmingham, Alabama
- +49 more
Nov 9, 2018
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma Trial in Memphis (Cyclophosphamide,
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- +6 more
- Cyclophosphamide
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 24, 2017
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,
Terminated
- Myelodysplastic Syndrome
- +9 more
-
Phoenix, Arizona
- +6 more
Feb 13, 2018
Leukemia Trial in Minneapolis (cyclosporine, cytarabine, filgrastim)
Terminated
- Leukemia
- cyclosporine
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Dec 3, 2017
Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in New York City (Gemtuzumab
Terminated
- Acute Myeloid Leukemia
- +2 more
- Gemtuzumab Ozogamicin
- +6 more
-
New York City, New YorkMorgan Stanley Children's Hospital of NYP
Apr 20, 2015
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in Memphis (Plerixafor)
Completed
- Acute Lymphoblastic Leukemia
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 31, 2013